anthonyyazdaniml/gliner-biomed-curated-corpus huggingface dataset:
The present invention provides a kind of for alleviating the composition of skin irritatin, the composition includes 4- tert. butyl cyclohexanol glucoside as active material, the content of 4- tert-butyl ring ethyl alcohol glucoside is 0.1-10% in the composition, and more preferably the content of 4- tert-butyl ring ethyl alcohol glucoside is 0.1-5% in composition.The present invention provides two kinds of methods for preparing 4- tert. butyl cyclohexanol glucoside in the composition simultaneously.A kind of composition for alleviating skin irritatin provided by the invention passes through the receptors such as the TRPV1 of inhibition receptor, the conduction of itch nerve is blocked, have the function of alleviating skin irritatin, and erythema caused by UV irradiates can be alleviated, 4- tert. butyl cyclohexanol glucoside is new molecular structure simultaneously, it is soluble easily in water compared with parent 4- tert. butyl cyclohexanol, overcome the shortcomings that 4- tert. butyl cyclohexanol is insoluble in water.
Treatment with \[225Ac\]Ac-FL-020 administered intravenously. 10 patients will also receive \[111In\]In-FL-020 for dosimetry purposes.
MIRALAX 3.4 to 4.9 g/kg up to a maximum of 238 g is reconstituted with non-carbonated, clear beverage, or water and administered in increments of 4 ounce (oz) for every 30 minutes, one day before colonoscopy between 5:00 PM and 9:00 PM. Following dosing, participants will consume 50 mL/kg of clear liquids, up to a limit of 1,000 mL total weight-based maximum.
Sertraline hydrochloride treatment should be initiated with a dose of 25 mg once daily in children (ages 6–12) and at a dose of 50 mg once daily in adolescents (ages 13–17).

While a relationship between dose and effect has not been established for OCD, patients were dosed in a range of 25–200 mg/day in the clinical trials demonstrating the effectiveness of sertraline hydrochloride for pediatric patients (6–17 years) with OCD. Patients not responding to an initial dose of 25 or 50 mg/day may benefit from dose increases up to a maximum of 200 mg/day. For children with OCD, their generally lower body weights compared to adults should be taken into consideration in advancing the dose, in order to avoid excess dosing. Given the 24 hour elimination half-life of sertraline hydrochloride, dose changes should not occur at intervals of less than 1 week.

Sertraline hydrochloride should be administered once daily, either in the morning or evening.
The present invention relates to a pharmaceutical composition for preventing or treating sepsis comprising Morin as an active ingredient. Further, the present invention relates to a food composition and feed composition for preventing or ameliorating sepsis comprising Morin as an active ingredient. According to the present invention, Morin or morin hydrate improves weight and viability in a septic animal model, recovers RBCs/WBCs damages, improves cellular viability of macrophage, and intracranial parametrically or histopathologically suppresses liver damages. Further, the Morin or morin hydrate according to the present invention activates antioxidant defense system and lowers ROS in cells. Further, the Morin or morin hydrate reduces inflammation, weakens cell survival through AKT signaling and induces activation of an NF-κB complex, and activates pyroptosis through a case-1 parametric path. Therefore, the Morin or morin hydrate is expected to be used as a natural remedy effective in treatment or amelioration of sepsis or septic shock.
In the first neuromodulation session, participants will receive rTMS using their optimal TMS frequency. After washout period of 1 week (minimum), the participants will start their second neuromodulation session using their sub-optimal TMS frequency instead.
Engineering vascularized tissues remains a promising approach for treating ischemic cardiovascular diseases. The availability of 3D-bioprinted vascular grafts that induce therapeutic angiogenesis can help avoid necrosis and excision of ischemic tissues. Here, using a combination of living cells and biodegradable hydrogels, we fabricated 3D-printed biocompatible proangiogenic patches from endothelial cell-laden photo-crosslinked gelatin (EC-PCG) bioink and smooth muscle cell-encapsulated polyurethane (SMC-PU) bioink. Implantation of 3D-bioprinted proangiogenic patches in a mouse model showed that EC-PCG served as an angiogenic capillary bed, whereas patterned SMC-PU increased the density of microvessels. Moreover, the assembled patterns between EC-PCG and SMC-PU induced the geometrically guided generation of microvessels with blood perfusion. In a rodent model of hindlimb ischemia, the vascular patches rescued blood flow to distal tissues, prevented toe/foot necrosis, promoted muscle remodeling, and increased the capillary density, thereby improving the heat-escape behavior of ischemic animals. Thus, our 3D-printed vascular cell-laden bioinks constitute efficient and scalable biomaterials that facilitate the engineering of vascular patches capable of directing therapeutic angiogenesis for treating ischemic vascular diseases.
This invention relates to a mini-type electric vehicle, which is mainly used for individual person or traffic in a certain field. It includes frame, seat, front & rear wheel, driving device, battery, steering system and front wheel suspension device. A casing, where the battery is placed on, protrudes forward at the middle position of the front end of the frame; the suspension device for front wheel appears “Front convex & rear concave” shape and covers the front end of that casing, and pivots to the middle of the front end of the casing. Two front wheels are installed on the front wheel suspension device. The rear edge line of the two front wheels is located at the rear of the battery front edge; Steering system is connected to the front end of the frame and interlocks with the front wheel. Battery is installed at the front so as to balance the weight distribution, improve the driving safety, comfort and steering performance for electric vehicle.
In the past 3 decades, advances in the understanding of the resuscitation of cardiac arrest have provided opportunities to strengthen the links in the chain of survival. Despite the apparent progress, however, survival has remained poor. Cardiac arrest is a leading cause of mortality in the US, accounting for up to 450,000 deaths annually. Eighty percent of all cardiac arrest events are caused by the arrhythmia, ventricular fibrillation. Prompt electrical defibrillation is the only effective therapy. The time interval from collapse to attempted defibrillation is the most important determinant of outcome. The chance of survival decreases on average by approximately 10-15% for every minute that elapses prior to attempted defibrillation. Thus, methods to decrease the time interval between collapse and electrical defibrillation represent a true opportunity to improve survival from cardiac arrest.

Even in communities where emergency medical systems are best situated to treat cardiac arrest, response intervals are on average greater than 6 minutes. The development of the automated external defibrillator (AED) provides the possibility to decrease the interval from collapse to defibrillation by enabling persons outside the traditional emergency medical services response system who are typically not trained in rhythm recognition to deliver life-saving therapy. The AED is a device that can be applied in case of cardiac arrest and will assess the heart rhythm and instruct the bystander whether to provide a shock. In addition, approximately 75% of cardiac arrests occur in the home and are witnessed or found by a family member. Thus, a family responder AED program, where family members of persons at relatively high risk of cardiac arrest are equipped and trained with AEDs, may in part, decrease the interval from collapse to shock in cardiac arrest and improve outcome. Persons who have recently been hospitalized for an acute coronary syndrome are known to be at elevated risk for cardiac arrest. Indeed, the provision of an AED for home use is already in practice. However, it is not clear what method should be used to train family members in this potentially lifesaving set of skills. The purpose of the proposed study is to evaluate 4 different AED training methods to determine if the training approaches differentially affect AED skill retention or psychological status. Although the programs span the spectrum from streamlined to personalized and intensive, each approach constitutes a potential real-world, generalizable AED training method.
BACKGROUND: The only treatment proven to be renoprotective in autosomal dominant polycystic kidney disease (ADPKD) is a vasopressin V2-receptor antagonist (V2RA). However, aquaresis-associated side effects limit tolerability. We investigated whether salt and/or protein intake influences urine volume and related endpoints in V2RA-treated ADPKD patients.
METHODS: In this randomized, controlled, double-blind, crossover trial, ADPKD patients treated with maximally tolerated dose of a V2RA were included. While on a low salt and low protein diet, patients were given additional salt and protein to mimic regular intake, which was subsequently replaced by placebo in random order during four 2-week periods. Primary endpoint was change in 24-h urine volume. Secondary endpoints were change in quality of life, measured glomerular filtration rate (mGFR), blood pressure and copeptin level.
RESULTS: Twelve patients (49 ± 8 years, 25.0% male) were included. Baseline salt and protein intake were 10.8 ± 1.3 g/24-h and 1.2 ± 0.2 g/kg/24-h, respectively. During the low salt and low protein treatment periods, intake decreased to 5.8 ± 1.6 g/24-h and 0.8 ± 0.1 g/kg/24-h, respectively. Baseline 24-h urine volume (5.9 ± 1.2 L) decreased to 5.2 ± 1.1 L (-11%, P = .004) on low salt and low protein, and to 5.4 ± 0.9 L (-8%, P = .04) on low salt. Reduction in 24-h urine volume was two times greater in patients with lower urine osmolality (-16% vs -7%). Polyuria quality of life scores improved in concordance with changes in urine volume. mGFR decreased during the low salt and low protein, while mean arterial pressure did not change during study periods. Plasma copeptin decreased significantly during low salt and low protein periods.
CONCLUSION: Lowering dietary salt and protein intake has a minor effect on urine volume in V2RA-treated ADPKD patients. Reduced intake of osmoles decreased copeptin concentrations and might thus increase the renoprotective effect of a V2RA in ADPKD patients.
FIELD: medicinal industry. SUBSTANCE: urine from pregnant women (8-12 weeks of gestation) is cleared passing through microfiltration diaphragms at pore size 0.22-0.5 mcm. The cleared raw is concentrated in ultrafiltration modulus with hollow fibers at cutting off limit 10-40 kDa. The obtained concentrate is washed off urea and salts with distillated water at pH = 5.8-7.0. Value pH of concentrate is brought about to 3.8-4.2 and precipitate containing chorionic gonadotropin is isolated by acetone excess addition. For reprecipitation of active deposit containing chorionic gonadotropin the deposit is dissolved in 5-10% ammonium-acetate buffer containing 50-70% ethanol. Precipitation of the end product is carried out by increase of ethanol concentration up to 90-92%. Activity of the obtained product is 1500-2000 U/mg, yield is 85.7-90%. EFFECT: improved method of preparing, increased yield and activity.
When adverse reactions occur, they are most commonly of the hypersensitivity type such as skin rashes, urticaria and rarely, angioneurotic edema or erythema multiforme-like drug reaction, and may necessitate withdrawal of therapy and appropriate countermeasures. Paresthesias of the hands and feet have been reported rarely after extended therapy. Other side effects reported occasionally are oral thrush, nausea, vomiting, epigastric distress, diarrhea, headache, fatigue, dizziness, insomnia, mental confusion and impairment of performance of routine activities.   


Proteinuria and leukopenia have been reported rarely. Administration of the drug should be discontinued if granulocytopenia occurs.   


When rare, serious reactions occur with griseofulvin, they are usually associated with high dosages, long periods of therapy, or both.
Little is known about how individuals learn to utilize robot-trained movements during upper extremity (UE) activities in the home and community and whether specific instruction can enhance motor learning and carry-over.. Systematic reviews of robot-assisted therapy for the paretic UE confirm gains in motor capacity as measured by clinical assessments, but provide little evidence of improved UE performance during daily tasks and occupations. These findings may be attributed to the limited availability of rehabilitation robots to train the paretic hand and a primary focus on intensity of practice with little regard for other principles of motor learning and experience-dependent neuroplasticity. These principles, including the salience of training tasks, transfer of acquired skills to similar activities, and active engagement and problem solving, are key to task-oriented training paradigms in stroke (e.g. constraint-induced movement therapy) but have not been well integrated into robot-assisted therapy protocols. The transfer of robot-trained movements to UE activities within the home and community needs further exploration before widespread use in rehabilitation practice is expected.
The investigators propose a 3 arm randomized clinical trial to test strategies designed to enhance literacy promotion for low-income Latino families. The investigators will recruit 630 parent-child dyads from community health centers that serve low-income, Latino families. Parents will be randomly assigned to one of 3 arms (1) Reach Out and Read (ROR) an evidence-based literacy promotion intervention that is widely disseminated in primary care; (2) ROR plus tailored outreach text messages; (3) ROR plus tailored outreach text messages and enhanced access to poverty-reducing resources using a widely disseminated model that simplifies access and provides care coordination. In Aim 1, the investigators will test their hypotheses that (1) children in the ROR plus text message arm will have higher scores on validated assessments of language and social-emotional development compared to standard ROR alone and (2) children who receive both text messages and enhanced access to poverty-reducing resources will have higher scores compared to the other two arms. In Aim 2, the investigators will examine mechanisms that underlie the effects of the interventions. In Aim 3, the investigators will use mixed methods to conduct a process evaluation to understand how the interventions are implemented, identify barriers, facilitators, and modifications, and explore parents' experiences with the interventions.
Schizophrenia is a severely debilitating psychiatric disorder that afflicts approximately 1% of the population (American Psychiatric Association, 1994) and is a serious public health problem. The specific mechanism of schizophrenia remains unknown. Affective responsivity and adaptive social behaviors are fundamental impairments in people with schizophrenia. These features have a detrimental impact on function in many areas of daily life. Unfortunately, the brain mechanisms that underlie these problems are still not understood. This study will use positron emission tomography (PET) and regional cerebral blood flow (rCBF) measures to ascertain the timing (1.5 hour period) of OT action on absolute regional brain activity in schizophrenia (SZ) and healthy control (HC) subjects. Particular focus will be on the amygdala, ventral striatum, anterior hippocampus and hypothalamus (neural regions involved in affliative behavior). Subjects will be studied with intranasally administered oxytocin and placebo while at rest and while making judgments about emotional faces. This approach will tell us to what extent the amygdala and limbic system's physiological response to oxytocin is predictive of a subject's behavioral sensitivity to this neuropeptide. The elucidation of this information may have a significant impact on predicting functional outcome and novel drug treatments in schizophrenia.

Functional magnetic resonance imaging (MRI) studies show that oxytocin modulates the amygdala's response during social and emotional decisions. When administered intranasally, OT may be beneficial for the treatment of negative symptoms in schizophrenia by enhancing a person's affiliative behavior and diminishing distrust. It is not, however, known to what extent intranasal oxytocin modifies regional neurotransmission and human brain metabolism. There are at present no studies in animals or humans specifically examining the time course action of OT on whole brain activity.
Chronic kidney disease (CKD) stands out as a rapidly increasing important health problem globally. CKD is a universal public health priority associated with significantly higher morbidity and mortality and excessive health care costs. The most common form of renal replacement therapy is hemodialysis. In patients with chronic kidney disease treated with hemodialysis, the disappearance of the survival advantage of women over men in the general population deeply affects the life experience of women. Among the additional difficulties that women face in this process compared to men, the inability to maintain their emotional resilience, failure to comply with treatment, and failure to meet their social support needs come to the fore.

The problems caused by hemodialysis and chronic illness create a significant burden on women, both materially and spiritually, and negatively affect women's quality of life. Common and common conditions include sleep disorders, fatigue, depression and pain. In addition, higher levels of sexual dysfunction have been reported in women with hemodialysis, and it has been stated that loss of sexuality may reduce self-confidence and cause problems in marriage. Chronic hemodialysis patients, especially female patients, should be supported in terms of sexual dysfunctions and psychosocial conditions. Therefore, health professionals should evaluate the psychosocial lives of especially female patients and provide the necessary support. Health professionals' use of complementary approaches to reduce patients' problems and improve their negative emotional states increases the effectiveness of medical treatment.

Reflexology and therapeutic touch are among the low-cost and complication-free nursing interventions. These nursing interventions can be used together with medical treatments to reduce stress and balance the body. Studies indicate that reflexology application and therapeutic touch can be effective in improving sexual function and positive emotions. However, when the literature is examined, it is observed that there are no studies evaluating therapeutic touch intervention in women receiving hemodialysis treatment, and reflexology studies are quite inadequate. Therefore, our study aims to examine the effects of foot reflexology and therapeutic touch on fatigue, depression and sexual quality of life in women receiving hemodialysis treatment.
Disclosed are a plaster pack composition for skin massage having functions of burn prevention and convenience and a manufacturing method thereof. The present invention relates to a plaster pack composition for skin massage which includes a heating component to easily remove waste and supply nutrients by expansion of pores by heating of the heating component, and a manufacturing method thereof. A conventional plaster pack does not have nutrients to mandate use of essence or nourishing cream before using the plaster pack, and has inconvenience of having to use the plaster pack by mixing plaster and water. Specifically, users frequently get burned by overheating by improperly adjusting the amount of plaster and water. The plaster pack composition for skin massage comprises 10-50 parts by weight of a mixed solvent in which glycerin, butylene glycol, and propylene glycol are mixed, 10-40 parts by weight of crystalline aluminosilicate which is a heating agent, 10-30 parts by weight of mixed powder of auxiliary inorganic powder and plaster powder which is an adsorbent, 1-20 parts by weight of a thickener, 0.1-0.3 parts by weight of a preservative, and 5-10 parts by weight of a natural additive without water. A material without water is used to prevent solidification heat of plaster to use only an adsorption function of plaster. Crystalline aluminosilicate is used for heating. Nutrients are included to provide user convenience and prevent overheating to provide safety while maintaining effects of a conventional plaster pack.
Repetitive transcranial magnetic stimulation (rTMS) is a noninvasive and painless procedure to modulate cortical excitability of motor areas and induce changes over the descending corticospinal output. This modulation may be useful to promote active recovery of motor function and to obtain functional benefit from gait rehabilitation. Through the use of repetitive high-frequency rTMS, improvement has been reported in motor and sensory functions measured by American Spinal Cord Injury Association (ASIA) Impairment Scale (AIS), and time to complete a peg-board task in four chronic incomplete cervical SCI patients.

Physical therapy aims to improve function of both undamaged and also, as far as possible, damaged neuronal structures. However, 'reorganization' of neuronal circuits is the target of specific training approaches. Therefore, the challenge is to guide CNS plasticity in order to optimize the functional outcome for a given individual. Hypothesized was that high-frequency rTMS coupled with gait training can improve motor recovery in the lower extremities and locomotion in incomplete SCI patients to a greater degree than sham stimulation.
The protracted form of COVID-19 known as 'long covid' was first described in 2020. Its symptoms, course and prognosis vary widely; some patients have a multi-system, disabling and prolonged illness. In 2021, ring-fenced funding was provided to establish 90 long covid clinics in England; some clinics were also established in Scotland and Wales. The NIHR-funded LOCOMOTION project implemented a UK-wide quality improvement collaborative involving ten of these clinics, which ran from 2021 to 2023. At regular online meetings held approximately 8-weekly, participants prioritised topics, discussed research evidence and guidelines, and presented exemplar case histories and clinic audits. A patient advisory group also held a priority-setting exercise, participated in quality meetings and undertook a service evaluation audit. The goal of successive quality improvement cycles aimed at changing practice to align with evidence was sometimes hard to achieve because definitive evidence did not yet exist in this new condition; many patients had comorbidities; and clinics were practically constrained in various ways. Nevertheless, much progress was made and a series of 'best practice' guides was produced, covering general assessment and management; breathing difficulties; orthostatic tachycardia and other autonomic symptoms; fatigue and cognitive impairment; and vocational rehabilitation. This paper summarises key findings with the frontline clinician in mind.